Weekly Overview

Posted by Rufas Kamau -
Scope Markets

Weekly Overview

Last Week

Last week was highly volatile as major trends were reversed in Forex, equities, and commodities markets. The Hang Seng index recorded the worst week in a year as it dropped 6.30%. The Dow ended the week 1.40% lower after trending at an all-time high of $32,082. The S&P dropped 2.30% while the Nasdaq dropped 5.20%.

Weekly Overview Scope Markets

This was as a result of US 10-year bond yields rising to 1.614% which briefly surpassed the S&P 500 dividend yield. Government bonds are considered as risk-free assets. So, when equities yields are surpassed by bond yields, it implies that more investors prefer the government bond to equities. Equities are considered as riskier assets relative to bonds.

Extreme weather in Texas and Germany continued ravaging renewable energy resources and forcing oil rigs to close. This led to higher oil prices as oil production was cut by at least 2 million barrels per day. Both US WTI oil and UK Brent oil closed the week at least 5% up.

Global semiconductor shortage continued as chipmaker stocks continued erasing gains. Nvidia, Intel, AMD, and Qualcomm ended the week roughly 5% down save for Applied Materials which closed 1% up. This shortage forced American automakers to halt vehicle production leading to lower stock prices.

Next Week

US 10-year and 5-year bond yields are expected to continue dominating the markets this week. If they continue rising, we could experience a further sell-off in equities.

Gamestop Saga round two is expected to continue this week. Last week, Gamestop shares surged 145% after Keith Gill testified to the US Congress. The retail trader popularly known as Roaring Kitty on Reddit, WallStreetBets, was grilled by the US Congress for allegedly starting the frenzy that forced a short squeeze on Gamestop and a couple of other shares that were heavily shorted.

Global vaccination reached 47.6 million as the US hit 21.6 million full vaccinations count. That is 6.57% of the US population. This high rate of vaccinations increased optimism about easing covid-19 restrictions which created a higher demand for stocks in air travel, taxi-hailing services, hotel services, and tourism.

Chinese manufacturing data will be expected on Sunday while the US ISM manufacturing data will be expected on Monday. On Tuesday, the Reserve Bank of Australia is expected to release interest rate data as well as the rate statement. Canadian and Australian GDP will follow on Tuesday and Wednesday respectively. Thursday will be dominated by OPEC meetings and a speech by FED chair Powell. The week will end with US non-farm payroll data.

Novartis, Zoom, Broadcom, Costco Wholesale, Target Corp, Sberbank, Snowflake, Merck, London Stock Exchange, Fiat Chrysler, and Prudential will all be expected to release their earnings reports this week.

The USD is expected to continue its bullish momentum. This started last week as bond yield fears drove equities lower and the dollar index higher.

Assets to Watch

  1. Moderna

Moderna is expected to rise further as Jim Cramer talked about the development of messenger-RNA based vaccine against certain forms of cancer. The biotech company closed the day on Friday 4% up. The company expects to make $18.4B in full-year 2021 sales of its Covid-19 vaccine. This is expected to be achieved by selling 700 million doses with plans to further extend the production to 1 billion doses.

In the last quarter, Moderna sold $570.75B in revenue compared to an analyst expectation of $279.4B. The stock could skyrocket on vaccine sales and cancer vaccine bets.

  • Vanguard Energy ETF

This is an exchange-traded fund that tracks the investment return of a basket of stocks in the energy sector. The energy sector outperformed the tech sector by 24% in February 2021. This could be a signal of a much wider shift in investing trends. As of this moment, a rising number of Wallstreet investors is citing fears about highly overvalued tech stocks in the US. The ETF was up 23% in February 2021 and 29.50% year-to-date.

Global vaccination rollout is raising hopes of a fully reopened global economy. This is set to raise energy demand as well as energy prices. The current stunt by OPEC+ countries to reduce oil production is also expected to drive oil prices higher. Additionally, a proposed $2T spending in infrastructure in the US is also set to benefit energy stocks.

Rufas Kamau

Research & Markets Analyst

Scope Markets

Share this article:

Disclaimer: This material is a marketing communication and shall not in any case be construed as an investment advice, investment recommendation or presentation of an investment strategy. The marketing communication is prepared without taking into consideration the individual investors personal circumstances, investment experience or current financial situation. Any information contained therein in regardsto past performance or future forecasts does not constitute a reliable indicator of future performance, as circumstances may change over time. Scope Markets shall not accept any responsibility for any losses of investors due to the use and the content of the abovementioned information. Please note that forex trading and trading in other leveraged products involves a significant level of risk and is not suitable for all investors.

Payment Methods

Scope Markets
Scope Markets
Scope Markets
Scope Markets


Scope Markets
Scope Markets
Scope Markets
Scope Markets

Scope Markets offers institutional and retail trading services to businesses and traders worldwide. Our top management team has more than 20 years of experience in the industry, and we are proud of the solid partnerships we built over the years. Whether it's a business or individual, Scope Markets has a wide range of trading solutions that are compliant, flexible, cost-efficient, innovative, and place the client first.

Contact Us

Registered address:
6160, Park Avenue, Buttonwood Bay, Lower Flat Office Space Front, Belize City, Belize


+44 2030 516959

Risk Warning

Please note that forex trading and trading in other leveraged products involves a significant level of risk and is not suitable for all investors. Trading in financial instruments may result in losses as well as profits and your losses can be greater than your initial invested capital. Before undertaking any such transactions, you should ensure that you fully understand the risks involved and seek independent advice if necessary. Please read and ensure you fully understand our Risk Disclosure.

Legal Information

RS Global Ltd is authorized and regulated by the Financial Services Commission of Belize ("FSC") under the Securities Industry Act 2021 with registration number 000274/2.

Restricted Regions

Scope Markets does not offer its services to the residents of certain jurisdictions. Please read carefully our Restricted Countries document.

This website uses cookies to provide you with the very best experience and to know you better. By visiting our website with your browser set to allow cookies, you consent to our use of cookies as described in our Privacy Policy.

© Copyright 2022 Scope Markets. All Rights Reserved.